BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29794416)

  • 21. Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo.
    Yao D; Pan D; Zhen Y; Huang J; Wang J; Zhang J; He Z
    Pharmacol Res; 2020 Feb; 152():104605. PubMed ID: 31863866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
    Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
    Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site.
    Hu X; Li L; Zhang Q; Wang Q; Feng Z; Xu Y; Xia Y; Yu L
    Bioorg Chem; 2020 Apr; 97():103695. PubMed ID: 32120073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.
    Li W; Sun H; Xu F; Shuai W; Liu J; Xu S; Yao H; Ma C; Zhu Z; Xu J
    Bioorg Chem; 2019 Apr; 85():49-59. PubMed ID: 30599412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
    Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
    Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities.
    Komuraiah B; Ren Y; Xue M; Cheng B; Liu J; Liu Y; Chen J
    Chem Biol Drug Des; 2021 May; 97(5):1109-1116. PubMed ID: 33638903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.
    Lindamulage IK; Vu HY; Karthikeyan C; Knockleby J; Lee YF; Trivedi P; Lee H
    Sci Rep; 2017 Aug; 7(1):10298. PubMed ID: 28860494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
    Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
    Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
    Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
    Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
    Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
    Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells.
    Thomas E; Gopalakrishnan V; Hegde M; Kumar S; Karki SS; Raghavan SC; Choudhary B
    Sci Rep; 2016 Oct; 6():34653. PubMed ID: 27748367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors.
    Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2020 Jul; 197():112308. PubMed ID: 32339853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.
    Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X
    Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of imidazo-thiadiazole linked indolinone conjugates and evaluated their microtubule network disrupting and apoptosis inducing ability.
    Narasimha Rao MP; Nagaraju B; Kovvuri J; Polepalli S; Alavala S; Vishnuvardhan MVPS; Swapna P; Nimbarte VD; Lakshmi JK; Jain N; Kamal A
    Bioorg Chem; 2018 Feb; 76():420-436. PubMed ID: 29275261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.